Therefore, reduced levels of LINC01003 might play a crucial role in the dysregulated inflammation that could occur in response to TLR9 stimulation, particularly in situations where RBC-TLR9 levels are reduced due to treatments or cancer. The gene discussed is LINC01003; the disease is cancer.